{"id":5953,"date":"2014-04-25T09:10:17","date_gmt":"2014-04-25T13:10:17","guid":{"rendered":"https:\/\/www.bu.edu\/bioinformatics\/?p=5953"},"modified":"2014-04-25T09:10:17","modified_gmt":"2014-04-25T13:10:17","slug":"special-bioinformatics-seminar","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/bioinformatics\/2014\/04\/25\/special-bioinformatics-seminar\/","title":{"rendered":"Special Bioinformatics Seminar"},"content":{"rendered":"<h3><b>Special Bioinformatics Seminar<\/b><\/h3>\n<h3><b>Monday 4\/28 @ 5:30 pm LSEB B01 &#8211; 24 Cummington Mall<\/b><\/h3>\n<p>&nbsp;<\/p>\n<h3><b>Analytical Challenges in Clinical Cancer Diagnostics by NGS<\/b><\/h3>\n<h3><b>Doron Lipson, PhD<\/b><\/h3>\n<h3>Senior Director, Computational Biology Methods at <a href=\"http:\/\/www.foundationmedicine.com\/\" target=\"_blank\">Foundation Medicine<\/a> in Cambridge<\/h3>\n<p>Dr. Lipson has over 10 years of experience in developing genomic applications. He is currently leading a team responsible for developing clinical-grade computational methods for detecting driver alterations in tumors from NGS data at Foundation Medicine. Previously, he has worked at Helicos BioSciences and at Agilent, and was a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Dr. Lipson received his Ph.D. in Computer Science from Israel Institute of Technology, and his B.S. in Computer Science and Biology from the Hebrew University of Jerusalem.<\/p>\n<p>Recent Publications<\/p>\n<p><a href=\"http:\/\/www.nature.com\/ncomms\/2014\/140120\/ncomms4116\/full\/ncomms4116.html\" target=\"_blank\">Kinase fusions are frequent in Spitz tumours and spitzoid melanomas<\/a> Nature Communications \/ 20 January 2014<\/p>\n<p><a href=\"https:\/\/clincancerres.aacrjournals.org\/content\/20\/1\/68.full\" target=\"_blank\">A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma<\/a>\u00a0Clinical Cancer Research<cite> \/ 1 <\/cite>January 2014<i> \u00a0<\/i><\/p>\n<p><a href=\"http:\/\/clincancerres.aacrjournals.org\/content\/19\/24\/6696.long\" target=\"_blank\">BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition<\/a>\u00a0Clinical Cancer Research<cite> \/ <\/cite>15 December 2013<\/p>\n<p><a href=\"http:\/\/www.nature.com\/nm\/journal\/v19\/n11\/abs\/nm.3352.html\" target=\"_blank\">Oncogenic and drug-sensitive <i>NTRK1<\/i> rearrangements in lung cancer<\/a> Nature Medicine \/ 27 October 2013<\/p>\n<p><a href=\"http:\/\/www.nature.com\/nbt\/journal\/v31\/n11\/full\/nbt.2696.html\">Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing<\/a><\/p>\n<p>Nature Biotechnology \/ 20 October 2013<\/p>\n<p><a href=\"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/04\/10\/1078-0432.CCR-13-0295.abstract\" target=\"_blank\">Relapsed classic E-cadherin (CDH1) mutated invasive lobular breast cancer demonstrates a high frequency of HER2 (ERBB2) gene mutations<\/a>\u00a0Clinical Cancer Research<cite> \/ <\/cite>10 April 2013<\/p>\n<p>&nbsp;<\/p>\n<p>Host: Simon Kasif<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Special Bioinformatics Seminar Monday 4\/28 @ 5:30 pm LSEB B01 &#8211; 24 Cummington Mall &nbsp; Analytical Challenges in Clinical Cancer Diagnostics by NGS Doron Lipson, PhD Senior Director, Computational Biology Methods at Foundation Medicine in Cambridge Dr. Lipson has over 10 years of experience in developing genomic applications. He is currently leading a team responsible [&hellip;]<\/p>\n","protected":false},"author":1391,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11821,375],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/posts\/5953"}],"collection":[{"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/users\/1391"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/comments?post=5953"}],"version-history":[{"count":15,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/posts\/5953\/revisions"}],"predecessor-version":[{"id":5968,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/posts\/5953\/revisions\/5968"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/media?parent=5953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/categories?post=5953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/bioinformatics\/wp-json\/wp\/v2\/tags?post=5953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}